Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS ANNOUNCES UPSIZE TO AND PROVIDES ADDITIONAL DETAILS REGARDING ITS PROPOSED EQUITY FINANCING

23 November 2016

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OPSENS INC. ANNOUNCES UPSIZE TO AND provides additional details regarding its proposed equity financing Quebec City, Quebec, November 23, 2016 – Opsens Inc. (“Opsens” or the “Corporation”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that it has amended the terms of its…

Read more

Opsens Announces Equity Financing

23 November 2016

      NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Opsens Announces Equity Financing Quebec City, Quebec, November 22, 2016 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that it has filed a preliminary short form prospectus in connection with a proposed marketed offering of common…

Read more

OPSENS REPORTS RESULTS FOR 2016 – RECORD TOTAL REVENUES DRIVEN BY TENFOLD INCREASE IN FFR SALES

16 November 2016

Quebec City, Quebec, November 16, 2016 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2016. Highlights The OptoWire II, Opsens’ guidewire to measure Fractional Flow Reserve (“FFR”) has been authorized for sale in the U.S., Europe, Japan and Canada; FFR product sales FFR revenues were $2.1 million…

Read more